NMAD · Nomad Power Solutions, Inc.
$4.18
-0.02 (-0.48%)
At close · Aug 26
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, management has concluded that there is a substantial doubt regarding the Company's ability to continue as a going concern for a period of at least 12 months beyond the filing of this quarterly report. In addition, our independent registered public accounting firm, in their audit report to the financial statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2025, included an explanatory paragraph regarding substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$68.11M
Shares
16.10M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Eric J. Forman | — | $200,000 |
| Robert N. Weingarten | — | $175,000 |
| James S. Miser | — | $102,083 |
| Dr. Jan H.M. Schellens | — | $85,300 |
| René Bernards | Director | $50,438 |
| Regina Brown | Director | $42,374 |
| Yun Yen | Director | $40,994 |
| Stephen J. Forman | Director | $33,989 |
| John S. Kovach | — | — |
| Bas van der Baan | Director | — |
| Gil N Schwartzberg | Director | — |
| Philip F. Palmedo | Director | — |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Eric J. Forman | — | $200,000 |
| John S. Kovach | — | $190,860 |
| James S. Miser | — | $175,000 |
| Robert N. Weingarten | — | $175,000 |
| Yun Yen | Director | $78,131 |
| Regina Brown | Director | $78,131 |
| Stephen J. Forman | Director | $70,631 |
| Bas van der Baan | Director | $66,609 |
| René Bernards | Director | $62,500 |
| Philip F. Palmedo | Director | — |
| Gil N Schwartzberg | Director | — |
| Dr. Jan H.M. Schellens | — | — |
| Winson Sze Chun Ho | Director | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| John S. Kovach | — | $315,640 |
| Eric J. Forman | — | $244,459 |
| James S. Miser | — | $240,640 |
| Robert N. Weingarten | — | $240,640 |
| Bas van der Baan | Director | $170,394 |
| René Bernards | Director | $133,873 |
| Yun Yen | Director | $93,340 |
| Regina Brown | Director | $93,340 |
| Stephen J. Forman | Director | $85,840 |
| Philip F. Palmedo | Director | $84,408 |
| Gil N Schwartzberg | Director | $79,970 |
| Dr. Jan H.M. Schellens | — | — |
| Winson Sze Chun Ho | Director | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Gil N Schwartzberg | Director | $1,052,386 |
| Regina Brown | Director | $961,749 |
| Yun Yen | Director | $448,880 |
| Philip F. Palmedo | Director | $447,505 |
| Stephen J. Forman | Director | $443,866 |
| John S. Kovach | — | $250,000 |
| James S. Miser | — | $166,667 |
| Eric J. Forman | — | $156,667 |
| Robert N. Weingarten | — | $156,667 |
| Winson Sze Chun Ho | Director | $142,828 |
| René Bernards | Director | — |
| Bas van der Baan | Director | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| James S. Miser | — | $635,150 |
| Robert N. Weingarten | — | $447,306 |
| Eric J. Forman | — | $430,855 |
| Stephen J. Forman | Director | — |
| John S. Kovach | Director | — |
| Philip F. Palmedo | Director | — |
| Gil N Schwartzberg | Director | — |
| Regina Brown | Director | — |
| René Bernards | Director | — |
| Bas van der Baan | Director | — |
| Winson Sze Chun Ho | Director | — |
| Yun Yen | Director | — |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Winson Sze Chun Ho | Director | $47,265 |
| Stephen J. Forman | Director | $47,265 |
| Yun Yen | Director | $47,265 |
| Philip F. Palmedo | Director | $47,265 |
| Eric J. Forman | — | — |
| Regina Brown | Director | — |
| Gil N Schwartzberg | Director | — |
| John S. Kovach | Director | — |
| James S. Miser | — | — |
| Robert N. Weingarten | — | — |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Winson Sze Chun Ho | Director | $52,460 |
| Yun Yen | Director | $52,460 |
| Philip F. Palmedo | Director | — |
| Stephen J. Forman | Director | — |
| Robert N. Weingarten | — | — |
| Eric J. Forman | — | — |
| James S. Miser | — | — |
| John S. Kovach | Director | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| John Travaglini | Board | Appointed | 2026-07-02 |
| Stuart D. Porter | member of the Board | Appointed | 2026-06-01 |
| Lourdes Felix | member of the Board of Directors and Chair of the Audit Committee and member of the Compensation Committee | Appointed | 2025-09-04 |
| Guy Primus | member of the Board of Directors and a member of the Audit Committee and Compensation Committee | Appointed | 2025-09-04 |
| Peter Stazzone | Chief Financial Officer | Appointed | 2025-09-04 |
| Geordan Pursglove | President | Appointed | 2025-09-04 |
| Bas van der Baan | Board of Directors | Resigned | 2025-09-04 |
| Bas van der Baan | President | Resigned | 2025-09-04 |
| Robert Weingarten | Vice President and Chief Financial Officer | Resigned | 2025-09-04 |
| Regina Brown | Board of Directors | Resigned | 2025-09-04 |
| Rene Bernards | Board of Directors | Resigned | 2025-09-04 |
| Jan Schellens | Chief Medical Officer | Resigned | 2025-07-21 |
| Yun Yen | the Board | Resigned | 2025-07-21 |
| Stephen Forman | the Board | Resigned | 2025-07-21 |
| Michael Holloway | independent members of the Board | Appointed | 2025-07-21 |
| Jason Sawyer | independent members of the Board | Appointed | 2025-07-21 |
| Bastiaan van der Baan | Chairman of the Board of Directors | Resigned | 2025-06-17 |
| Bastiaan van der Baan | Chief Scientific Officer | Appointed | 2025-06-17 |
| Bastiaan van der Baan | Chief Executive Officer | Resigned | 2025-06-17 |
| Geordan Pursglove | Chairman of the Board of Directors | Appointed | 2025-06-17 |
| Geordan Pursglove | Chief Executive Officer | Appointed | 2025-06-17 |
| Eric Forman | Vice President and Chief Operating Officer | Resigned | 2024-12-27 |
| Dr. Jan H.M. Schellens, M.D., Ph.D. | Chief Medical Officer | Appointed | 2024-06-05 |
| James Miser | Chief Medical Officer | Terminated | 2024-05-29 |
| Bas van der Baan | director | Appointed | 2023-11-28 |
Key facts
CIK
1335105
CUSIP
539319301
13F (30d)
18 filings
17 filers
Visit website
Investor relations